Asset Details
Do you wish to reserve the book?
NID2 Affects Prognosis of Glioma via Activating the Akt Signaling Pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
NID2 Affects Prognosis of Glioma via Activating the Akt Signaling Pathway
Do you wish to request the book?
NID2 Affects Prognosis of Glioma via Activating the Akt Signaling Pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
NID2 Affects Prognosis of Glioma via Activating the Akt Signaling Pathway
2025
Overview
Nidogen-2 (NID2) is a critical component of the extracellular matrix (ECM), which plays a regulatory role in cell adhesion, migration, differentiation, and survival. Previous studies have shown that NID2 is deregulated in several types of cancer, but its role in glioma is unknown. The present study investigated the prognostic value of NID2 in glioma and its associated molecular pathways and functional roles in malignant progression. The performed analyses included investigating the NID2 expression profile using the Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), and tumor tissue microarray. The findings demonstrated that NID2 high expression predicts worse patient survival by both univariable and multivariable analyses. There is a strong correlation between NID2 upregulation and tumor grade. In stably NID2-overexpressed glioma cells, RNA-Seq analysis revealed coactivation of oncogenic functional pathways, including cell proliferation, survival, epithelial–mesenchymal transition, ECM organization, and migration. Overexpression of NID2 in U87MG and T98G cells promoted cell proliferation, migration, and invasion. TUNEL assay showed NID2 overexpression protected cells from apoptosis. Western blotting analysis showed activation of Akt and Bcl-xL in NID2-overexpressed cells. Our results show that NID2 is a promising prognostic marker in glioma.
Publisher
MDPI AG,MDPI
Subject
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Brain Neoplasms - metabolism
/ Cancer
/ Cell Adhesion Molecules - genetics
/ Cell Adhesion Molecules - metabolism
/ Cell Proliferation - genetics
/ Datasets
/ Epithelial-Mesenchymal Transition - genetics
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genomes
/ Genomics
/ Glioma
/ Gliomas
/ Humans
/ Male
/ Proteins
/ Proto-Oncogene Proteins c-akt - metabolism
/ RNA
/ Tumors
